Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962727 | Vaccine | 2016 | 12 Pages |
Abstract
Microneedle technology research has been focussed on demonstrating efficacy with minimal focus on determining HCP/public perception and acceptability for paediatric use, exemplified by the paucity of studies presented in this review. Commercial viability will depend on HCP/public acceptability of microneedle technology. An effort must be made to identify the barriers to acceptance and to overcome them by increasing awareness and education in stakeholder groups pertaining to the paediatric population.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sarah Marshall, Laura J. Sahm, Anne C. Moore,